Literature DB >> 25373689

Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.

Sabrina Zidi1, Hasibe Verdi2, Yaprak Yilmaz-Yalcin2, A C Yazici3, Ezzedine Gazouani4, Amel Mezlini5, Fatma-Belgin Atac2, Besma Yacoubi-Loueslati1.   

Abstract

Previous studies underscored the importance of genetic factors in the pathogenesis of certain cancers, including cervical cancer. Epidemiological evidence supports an association between specific polymorphisms of Toll-like receptors (TLR) with several human pathological states, including cervical cancer. The aim of this study was to investigate the link between specific gene variants in TLR2 (-196 to -174 del), TLR3 (c.1377 C>T), TLR4 (Asp299Gly), and TLR9 (2848 G>A) and susceptibility to cervical cancer in Tunisian women. Study subjects comprised 122 women with histopathologically-confirmed cervical cancer, and 260 unrelated age- and ethnically-matched healthy females, who served as controls. TLR genotyping was done using PCR-restriction fragment length polymorphism. The C/C genotype of TLR3 (c.1377 C>T) is associated with cervical cancer susceptibility (OR: 1.71, CI: 1.08-2.70). For TLR4 (Asp299Gly), the Asp/Asp genotype and the Asp allele were associated with higher risk of developing cervical cancer (OR: 4.95, CI: 1.97-13.22) and (OR: 5.17, CI: 2.11-13.50) respectively. We demonstrated no association between the TLR2 (-196 to -174 del) and the TLR 9 (2848 G>A) polymorphisms and the susceptibility of cervical cancer among Tunisian women. However, the C/C genotype for the TLR3 (c.1377 C>T) polymorphism and the Asp/Asp genotype and the Asp allele for (Asp299Gly) TLR4 polymorphism were found to be associated with a higher risk of cervical cancer.

Entities:  

Keywords:  PCR; Toll-like receptor; cervical cancer; gene polymorphism

Mesh:

Substances:

Year:  2014        PMID: 25373689     DOI: 10.1684/bdc.2014.2037

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  7 in total

1.  Association of toll-like receptor gene polymorphisms and its interaction with HPV infection in determining the susceptibility of cervical cancer in Chinese Han population.

Authors:  Ye Jin; Shuang Qiu; Na Shao; Jianhua Zheng
Journal:  Mamm Genome       Date:  2017-05-11       Impact factor: 2.957

2.  Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.

Authors:  Sabrina Zidi; Ikram Sghaier; Ezzedine Gazouani; Amel Mezlini; Besma Yacoubi-Loueslati
Journal:  Pathol Oncol Res       Date:  2015-11-09       Impact factor: 3.201

3.  Single Nucleotide Polymorphisms in IL-10, IL-12p40, and IL-13 Genes and Susceptibility to Glioma.

Authors:  Haidar A Shamran; Haidar F Ghazi; Ahmed Al-Salman; Ahmad A Al-Juboory; Dennis D Taub; Robert L Price; Mitzi Nagarkatti; Prakash S Nagarkatti; Udai P Singh
Journal:  Int J Med Sci       Date:  2015-09-19       Impact factor: 3.738

4.  Toll-like receptor 4 gene is associated with recurrent spontaneous miscarriage in Uygur and Han women in Xinjiang.

Authors:  Yonghui Jiao; Jing Zhao; Bo Hu; Xiaoling La; Xiaoyun Gong; Ying Huang; Xia Cai; Yi Zhang
Journal:  Exp Ther Med       Date:  2016-10-11       Impact factor: 2.447

5.  Increased risks between TLR2 (-196 to -174 ins/del) and TLR3 1377C>T variants and head and neck cancers in Tunisia.

Authors:  Lamia Makni; Sabrina Zidi; Mouadh Barbiroud; Amira Ben Ahmed; Ezzedine Gazouani; Amel Mezlini; Mouna Stayoussef; Besma Yacoubi-Loueslati
Journal:  Cent Eur J Immunol       Date:  2019-07-30       Impact factor: 2.085

6.  Molecular immune mechanisms of HPV-infected HaCaT cells in vitro based on toll-like receptors signaling pathway.

Authors:  Zuolin Ying; Xiaojie Li; Hong Dang; Na Yin; Chuang Gao
Journal:  J Clin Lab Anal       Date:  2019-11-29       Impact factor: 2.352

7.  -196 to -174del, rs4696480, rs3804099 polymorphisms of Toll-like receptor 2 gene impact the susceptibility of cancers: evidence from 37053 subjects.

Authors:  Sheng-Lin Gao; Yi-Ding Chen; Chuang Yue; Jiasheng Chen; Li-Feng Zhang; Si-Min Wang; Li Zuo
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.